LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $943,080 | -31.3% | 15,739 | -15.6% | 0.00% | -100.0% |
| Q2 2023 | $1,371,968 | 0.0% | 18,651 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,371,968 | +16.6% | 18,651 | +5.8% | 0.00% | 0.0% |
| Q4 2022 | $1,177,083 | -99.9% | 17,621 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,517,344,000 | -3.5% | 17,621 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,572,147,000 | -35.7% | 17,621 | -19.0% | 0.00% | 0.0% |
| Q1 2022 | $2,446,657,000 | -22.7% | 21,750 | +6.1% | 0.00% | 0.0% |
| Q4 2021 | $3,165,349,000 | +5.9% | 20,493 | -4.5% | 0.00% | 0.0% |
| Q3 2021 | $2,989,947,000 | +3.6% | 21,461 | -2.4% | 0.00% | 0.0% |
| Q2 2021 | $2,886,181,000 | +5.3% | 22,000 | +22.3% | 0.00% | 0.0% |
| Q1 2021 | $2,741,357,000 | +58.1% | 17,982 | +3.2% | 0.00% | 0.0% |
| Q4 2020 | $1,733,613,000 | -79.3% | 17,432 | -80.2% | 0.00% | -80.0% |
| Q3 2020 | $8,394,356,000 | +300.2% | 88,065 | +369.6% | 0.01% | +400.0% |
| Q2 2020 | $2,097,636,000 | +53.9% | 18,754 | +0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,363,210,000 | -81.6% | 18,746 | -73.6% | 0.00% | -80.0% |
| Q4 2019 | $7,393,015,000 | -0.1% | 70,889 | -4.6% | 0.01% | 0.0% |
| Q3 2019 | $7,399,605,000 | -12.4% | 74,338 | +0.5% | 0.01% | -16.7% |
| Q2 2019 | $8,442,419,000 | -10.6% | 73,959 | -1.5% | 0.01% | -14.3% |
| Q1 2019 | $9,438,181,000 | -5.5% | 75,079 | +2.0% | 0.01% | -22.2% |
| Q4 2018 | $9,985,485,000 | -53.4% | 73,585 | -5.7% | 0.01% | -43.8% |
| Q3 2018 | $21,423,670,000 | -1.9% | 78,049 | -25.9% | 0.02% | -5.9% |
| Q2 2018 | $21,834,475,000 | +17.4% | 105,394 | -6.4% | 0.02% | +13.3% |
| Q1 2018 | $18,601,971,000 | +18.6% | 112,630 | -1.6% | 0.02% | +15.4% |
| Q4 2017 | $15,678,759,000 | +0.6% | 114,502 | +0.0% | 0.01% | -7.1% |
| Q3 2017 | $15,584,955,000 | +11.2% | 114,469 | -0.8% | 0.01% | 0.0% |
| Q2 2017 | $14,009,318,000 | +7.2% | 115,398 | -6.5% | 0.01% | +7.7% |
| Q1 2017 | $13,066,265,000 | +99917.3% | 123,453 | -4.0% | 0.01% | -13.3% |
| Q4 2016 | $13,064,000 | -6.7% | 128,568 | -6.2% | 0.02% | 0.0% |
| Q3 2016 | $13,996,000 | -16.3% | 137,133 | -2.2% | 0.02% | -21.1% |
| Q2 2016 | $16,723,000 | +63.1% | 140,213 | +46.5% | 0.02% | +58.3% |
| Q1 2016 | $10,251,000 | -8.0% | 95,730 | -6.9% | 0.01% | -7.7% |
| Q4 2015 | $11,143,000 | +23.1% | 102,784 | -2.7% | 0.01% | +30.0% |
| Q3 2015 | $9,050,000 | -0.8% | 105,670 | +16.9% | 0.01% | +11.1% |
| Q2 2015 | $9,124,000 | +753.5% | 90,431 | +552.4% | 0.01% | +800.0% |
| Q1 2015 | $1,069,000 | +46.6% | 13,862 | +1.1% | 0.00% | 0.0% |
| Q4 2014 | $729,000 | +19.5% | 13,711 | +5.6% | 0.00% | 0.0% |
| Q3 2014 | $610,000 | -14.3% | 12,984 | +13.6% | 0.00% | 0.0% |
| Q2 2014 | $712,000 | -31.6% | 11,429 | -26.2% | 0.00% | 0.0% |
| Q1 2014 | $1,041,000 | +22.6% | 15,477 | -4.1% | 0.00% | 0.0% |
| Q4 2013 | $849,000 | -85.9% | 16,139 | -88.4% | 0.00% | -85.7% |
| Q3 2013 | $6,008,000 | -86.0% | 138,815 | -87.9% | 0.01% | -87.3% |
| Q2 2013 | $42,937,000 | – | 1,147,423 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |